Amgen Inc.
US ˙ NasdaqGS ˙ US0311621009

SecurityAMGN / Amgen Inc.
InstitutionJJJ Advisors Inc.
Latest Disclosed Ownership620 shares
Latest Disclosed Value $ 193,719
JJJ Advisors Inc. reports 14.72% decrease in ownership of AMGN / Amgen Inc.

On July 25, 2024 - JJJ Advisors Inc. filed a 13F-HR form disclosing ownership of 620 shares of Amgen Inc. (US:AMGN) valued at $193,719 USD as of June 30, 2024. The entity filed a previous 13F-HR on April 15, 2024 disclosing 727 shares of Amgen Inc.. This represents a change in shares of -14.72% during the quarter. The current value of the position is $216,740 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2024-07-25 2024-06-30 13F AMGEN COM 031162100 620 -107 -14.72 194 -6.31 0.0406
2024-04-15 2024-03-31 13F AMGEN COM 031162100 727 -30 -3.96 207 -5.50 0.0440
2024-01-29 2023-12-31 13F AMGEN COM 031162100 757 61 8.76 218 16.58 0.0526
2023-10-13 2023-09-30 13F AMGEN COM 031162100 696 377 118.18 187 167.14 0.0493
2023-07-11 2023-06-30 13F AMGEN COM 031162100 319 -103 -24.41 71 -33.33 0.0195
2023-04-21 2023-03-31 13F AMGEN COM 031162100 422 118 38.82 106 28.05 0.0299
2023-01-23 2022-12-31 13F AMGEN COM 031162100 304 77 33.92 82 54.72 0.0232
2022-10-17 2022-09-30 13F AMGEN COM 031162100 227 -218 -48.99 53 -51.82 0.0173
2022-08-03 2022-06-30 13F AMGEN COM 031162100 445 -36 -7.48 110 -5.98 0.0327
2022-05-05 2022-03-31 13F AMGEN COM 031162100 481 243 102.10 117 116.67 0.0323
2022-02-02 2021-12-31 13F AMGEN COM 031162100 238 -201 -45.79 54 -41.94 0.0162
2021-10-25 2021-09-30 13F/A-1 AMGEN COM 031162100 439 -5 -1.13 93 -13.89 0.0329
2021-10-19 2021-09-30 13F AMGEN COM 031162100 439 -5 93 0.0326
2021-07-28 2021-06-30 13F AMGEN COM 031162100 444 -24 -5.13 108 -6.90 0.0392
2021-04-28 2021-03-31 13F AMGEN COM 031162100 468 168 56.00 116 68.12 0.0463
2021-01-26 2020-12-31 13F AMGEN COM 031162100 300 236 368.75 69 331.25 0.0334
2020-10-19 2020-09-30 13F AMGEN COM 031162100 64 64 16 0.0086
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.